SARAH SCHULLER: Open Payments
NPI 1407463292 · ANKENY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,206 in 177 payments from 20 companies in 2025. Trend: 2023 $2,430 · 2024 $2,955 · 2025 $3,206
Food & beverage: $3,198Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $462 |
| Otsuka America Pharmaceutical, Inc. | 26 | $435 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $399 |
| Lundbeck LLC | 10 | $226 |
| Teva Pharmaceuticals USA, Inc. | 9 | $223 |
| MDD US Operations, LLC | 23 | $214 |
| Vanda Pharmaceuticals Inc. | 8 | $204 |
| Corium, LLC | 9 | $190 |
| E.R. Squibb & Sons, L.L.C. | 8 | $183 |
| Alkermes, Inc. | 5 | $100 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Qelbree, FANAPT, Azstarys, COBENFY, AUSTEDO XR.
Industry payments across IA — which companies pay providers there.
